Literature DB >> 2138505

Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents.

V E Steele1, G J Kelloff, B P Wilkinson, J T Arnold.   

Abstract

Twenty-eight compounds were screened for chemopreventive activity by using a rat tracheal epithelial cell transformation inhibition assay. In this new assay, chemicals were tested for their ability to inhibit the formation of transformed rat tracheal epithelial cell colonies which arise following exposure to the carcinogen benzo(a)pyrene. The 15 positive compounds were N-acetylcysteine, bismuththiol, calcium glucarate, (+/-) catechin, diallyl disulfide, glycaric acid, D-glucaro-1,4-lactone, N-(4-hydroxyphenyl)retinamide, D-limonene, mesna, retinoic acid, rutin, quercetin, silymarin, and taurine. In examining the nature of compounds that inhibited rat tracheal epithelial cell transformation, several possible chemopreventive mechanisms appeared to be predominant: compounds that were positive (a) increased glutathione levels or enhanced conjugation; (b) increased cytochrome P-450 activity; (c) displayed nucleophilic activity; or (d) induced differentiation. Thirteen compounds were negative in the rat tracheal epithelial transformation inhibition assay: crocetin, difluoromethylornithine, ellagic acid, esculetin, enoxalone, ibuprofen, levamisole, nordihydroguaiaretic acid, L-2-oxothiazolidine-4-carboxylate, piroxicam, sodium butyrate, D-alpha-tocopherol acetate, and polyethylene glycol 400. It was evident from these results that this assay would not detect compounds that were (a) anti-promoting in nature; (b) glutathione inhibitors; (c) differentiation inhibitors; (d) O6-methylguanine inhibitors; (e) organ specific; or (f) inactive. The rat tracheal epithelial cell transformation inhibition assay appeared to identify chemopreventive compounds that act at early stages of the carcinogenic process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138505

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Inhibition of plasma membrane NADH oxidase activity and growth of HeLa cells by natural and synthetic retinoids.

Authors:  S Dai; D J Morré; C C Geilen; B Almond-Roesler; C E Orfanos; D M Morré
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

2.  Critical variables controlling cell proliferation in primary cultures of rat tracheal epithelial cells.

Authors:  T Gray; J Rundhaug; P Nettesheim
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

3.  Assessment of hepatotoxicity of first-line anti-tuberculosis drugs on Wistar rats.

Authors:  Radhika Sharma; Ramneek Kaur; Manishi Mukesh; Vijay L Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-11-09       Impact factor: 3.000

4.  Factors regulating the emergence of spontaneous and X-ray-induced variants in primary rat tracheal epithelial cell cultures.

Authors:  M Terzaghi-Howe
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

5.  Differential activity of NO synthase inhibitors as chemopreventive agents in a primary rat tracheal epithelial cell transformation system.

Authors:  Sheela Sharma; Betty P Wilkinson; Pu Gao; Vernon E Steele
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

Review 6.  Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview.

Authors:  Divya Singh; William C Cho; Ghanshyam Upadhyay
Journal:  Front Physiol       Date:  2016-01-26       Impact factor: 4.566

Review 7.  Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review.

Authors:  Laiba Arshad; Ibrahim Jantan; Syed Nasir Abbas Bukhari; Md Areeful Haque
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

8.  Crocin Promotes Apoptosis in Human EBV-Transformed B-Lymphocyte via Intrinsic Pathway.

Authors:  Abdolreza Sotoodeh Jahromi; Mohammad Kargar; Farshid Kafilzadeh; Marzieh Jamalidoust; Maliheh Moradzadeh
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.